Georgia Society of Clinical Oncology

12/05/2025

The following GASCO corporate partners have recently received FDA new drug or new indication approvals:
💠Eli Lilly and Company
💠GSK
💠Jazz Pharmaceuticals
💠Regeneron
For more information: https://loom.ly/TeYvBhs

12/01/2025

FINAL DAY TO REGISTER
On behalf of Genentech, you are invited to attend an expert-led educational presentation:
IMforte regimen: The first and only FDA-approved combination for maintenance treatment in 1L ES-SCLC
A review of the trial data for the IMforte regimen (TECENTRIQ + lurbinectedin)
⚫Target Audience: MDs, PAs, NPs, RNs, Residents, Fellows, and PharmDs
⚫Speaker: Mark Socinski, MD, Executive Medical Director, AdventHealth Cancer Institute
⚫Date & Time: Tuesday, December 2, 2025, 6:00 pm ET
Details and registration at https://loom.ly/b1Uhz4E

11/24/2025

On behalf of Genentech, you are invited to attend an expert-led educational presentation:
IMforte regimen: The first and only FDA-approved combination for maintenance treatment in 1L ES-SCLC
A review of the trial data for the IMforte regimen (TECENTRIQ + lurbinectedin)
⚫Target Audience: MDs, PAs, NPs, RNs, Residents, Fellows, and PharmDs
⚫Speaker: Mark Socinski, MD, Executive Medical Director, AdventHealth Cancer Institute
⚫Date & Time: Tuesday, December 2, 2025, 6:00 pm ET
Details and registration at https://loom.ly/b1Uhz4E

11/21/2025

Urge Congress to protect and increase funding for lifesaving cancer research.

The federal government has reopened after the longest shutdown in history. Members of Congress are back at the negotiating table for their next spending bill, and your voice matters now.

This moment is critical to passing a bill that prioritizes funding for cancer research and prevention programs. Members of Congress are paying attention. Make sure they know your priorities by sending them a message.

https://loom.ly/7G-tIXw

ACS CAN is the leading cancer advocacy organization that is working every day to make cancer issues a national priority.

11/21/2025

As the season of gratitude arrives, it’s the perfect time to gather and celebrate the leaders, innovators, and future generations making remarkable strides in cancer care. The Giants of Cancer Care® award recognizes individuals who have made landmark contributions to oncology research and clinical practice.

Please join us in recognizing individuals who have achieved landmark successes within the global field of oncology by nominating a colleague or mentor who deserves to be inducted into the Giants of Cancer Care® class of 2026.
https://loom.ly/ZYTkDX4

11/17/2025

GASCO is thrilled to announce the launch of the first edition of the official GASCO pharmaceutical industry newsletter, 𝘗𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘕𝘦𝘸𝘴 & 𝘏𝘪𝘨𝘩𝘭𝘪𝘨𝘩𝘵𝘴: 𝘞𝘩𝘢𝘵 𝘖𝘯𝘤𝘰𝘭𝘰𝘨𝘪𝘴𝘵𝘴 𝘢𝘯𝘥 𝘊𝘭𝘪𝘯𝘪𝘤𝘪𝘢𝘯𝘴 𝘕𝘦𝘦𝘥 𝘵𝘰 𝘒𝘯𝘰𝘸. This exclusive resource is designed specifically for our valued members and corporate partners to be distributed monthly, fostering a more connected and informed community within the pharmaceutical sector. Our goal is to provide timely, relevant pharmaceutical news at the forefront of therapeutic developments.
https://loom.ly/xuHPlPg

11/11/2025

Piedmont opens Georgia's first early detection pancreatic cancer clinic. Georgia faces slightly higher pancreatic cancer rates than the national average. On Friday, Piedmont Oncology launched Georgia’s first stand-alone Early Detection Pancreatic Cancer Clinic at Piedmont Atlanta Hospital. The Clinic will provide risk assessments, increase awareness, and facilitate research for pancreatic cancer. Learn more at https://loom.ly/3jDVFLM

Georgia faces a slightly higher pancreatic cancer rates than the national average.

10/29/2025

LAST DAYS TO REGISTER
Register online at https://loom.ly/ClR9x1Y
23rd Annual School of Breast Oncology
November 6 - 8, 2025
Emory Conference Center Hotel, Atlanta GA
Free registration when you use the code GASCO

10/20/2025

ONE MORE WEEK!
The 19th Annual Atlanta Lung Cancer Symposium (ALCS) is a pioneering educational program addressing current, practical strategies, and state-of-the-art approaches for managing lung cancer, and offering updates on the latest clinical data. Practitioners attending ALCS will emerge from the program updated on recent data and armed with new tools to help them improve clinical outcomes. Visit the conference website for details at https://loom.ly/BCdjwfE

10/08/2025

REMINDER: Last Chance to Register!
The 19th Annual Atlanta Lung Cancer Symposium (ALCS) is a pioneering educational program addressing current, practical strategies, and state-of-the-art approaches for managing lung cancer, and offering updates on the latest clinical data. Practitioners attending ALCS will emerge from the program updated on recent data and armed with new tools to help them improve clinical outcomes. Visit the conference website for details at https://loom.ly/BCdjwfE

09/30/2025

Thyroid cancer is the most common endocrine cancer, with an increasing incidence worldwide. Early detection and treatment are crucial for successful outcomes. Early detection is key: Many forms of thyroid cancer are highly curable when found early.